Archean Chemical Industries Ltd.

Archean Chemical Industries Ltd.

439.50
INR
-4.15
(-0.94%)
7.99EPS
59.50P/E
59.98BMarket Cap
Feb 05Next Earn

Q1 FY2027 · Earnings Call TranscriptAugust 3, 2026

Operator

Ladies and gentlemen, good day, and welcome to Q1 FY27 earnings conference call of Archean Chemical Industries Limited. This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions, and expectations of the company as on date of this call.

These statements are not the guarantees of future performance and involve risks and uncertainties that are difficult to predict. As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during this conference call, please signal an operator by pressing star then zero on your touchtone phone. Please note that this conference is being recorded.

I now hand the conference over to Mr. Rampraveen Swaminathan, Managing Director.

Thank you, and over to you, sir.

Rampraveen Swaminathan

All right. Good morning, everyone, and a warm welcome to our Q1 FY27 earnings call.

Thank you for taking the time to join us today, and I hope you all are safe, especially those of you who are in weather-afflicted regions. On this call today, I am joined by Mr.

R. Natarajan, our CFO, Mr.

Rajeev Kumar, DGM Finance and Strategy, members of our finance team, and SGA, investor relations advisors. I hope you've had a chance to go through the results and the investor presentation, both of which are on our website and on the stock exchanges.

In my opening comments, I'll briefly cover the operating environment, key developments of the quarter, and our business and financial performance. Starting off, from an overall perspective, the focus in Q1 was on delivering to our commitments and driving the sequential performance in bromine and bromine derivatives, while optimizing industrial salt in a challenging external environment.

I believe that Q1 performance validates the actions we set out with all of you in the last call. On a standalone basis, revenue for the quarter was ₹3,321 million, up 14% year-on-year and up 9% sequentially.

This is our highest quarterly revenue in the last five quarters. EBITDA was ₹888.7 million, up 26.3% versus the sequential quarter, with margins expanding from 21.8% in Q4 of FY26 to 25.3% in the quarter under consideration.

Profit after tax on a fully consolidated basis, sorry, profit after tax on a standalone basis was ₹405.3 million, up 36% sequentially from the prior quarter. Margins were down year-on-year largely due to higher logistics costs and purchase price variance on various raw materials, which could not be fully offset by our operating performance.

On a consolidated basis, revenue for the quarter was ₹3,328.1 million, up 10.7% year-on-year. EBITDA on a fully consol basis was ₹728.7 million, up 48.5% sequentially, and profit after tax was ₹300.5 million, more than double the preceding quarter.

Year-on-year consolidated performance was affected by standalone business performance as well as the scaling costs of our semiconductor business. Three things drove our performance overall in the quarter, actually four things, but three of them are structural and I want to call them out.

Firstly, bromine volumes were the highest in the last five quarters, and realizations for the quarter are up 50% year-on-year. Secondly, our derivatives business, Acume, has turned EBITDA positive for the first time.

This has been an important area of strategic focus for us, and we continue to make good progress there. Thirdly, on sulphate of potash, trials of the phase, first phase one trials were successfully completed in June 2026.

We are in the process of doing our phase two trials by end of Q3 financial year, which will then validate the modified process for commercial production. Operationally, we continue to carry a headwind in industrial salt logistics, which I will address briefly in a while.

Both road logistics and sea freight increase have impacted our profitability. In addition to road logistics, sea freight costs have also increased by 30 to 35%, impacting our landed costs to customers in East and South Asia.

However, the shape of the business remains positive, and we are confident of entering H2 FY27 with stronger momentum. In terms, just a quick overview on our overall the markets and highlights on our business.

On the demand environment, bromine and bromine derivatives demand has remained firm across most geographies. The supply imbalance of the previous two quarters has normalized, but underlying demand from flame retardants, oil field chemicals, and energy storage applications remained healthy, and our pricing actions continue to hold.

Our bromine realization improvement reflects both the market and the approach we have applied to contracts and to customer selections. As the supply shortages have normalized, there has been a correction in pricing.

Landed prices in China, for example, have declined by 30 to 40% in the past 12 weeks. In this environment, we work we continue to work closely with our customers to ensure that we are able to sustain the improvements that we have made in pricing.

In industrial salt, the pricing environment has stabilized. After declines through most quarters in FY26, realizations in Q1 were broadly flat.

Competitive intensity remains high with new capacity additions in Australia and elsewhere, and the challenges of landed pricing which I have mentioned earlier. We are starting to see a floor in terms of market pricing, and our customer relationships and our market position remains fully intact.

The pricing challenge which we had is a reflection of the gap in South and East Asia of the gap in South and East Asia between landed prices from India versus landed price of domestic salt in those regions and salt they source from other regions. On the broad macroeconomic environment, the India-US trade discussions, the India-EU FTA negotiations, and the kind of new normal in the Middle East continue to shape trade flows.

Freight freight and fuel costs have remained, above pre-conflict levels. They actually increased in Q1 for us versus Q4, though they have now started to ease.

The conflict in the Middle East has continued to impact demand from QVC, an important customer of ours for salt, and also offtake of derivatives from the oil and gas segment, which has seen volatility because of this. However, we continue to see good traction, customer interest in new account additions, which has helped us offset some of this volatility.

An important element for us during the quarter obviously has been logistics. As mentioned earlier, in the last quarter, we've been impacted both by an increased freight distance and the fuel costs contributed to higher diesel prices.

The road construction on the corridor from the Hajipir plant to the Jakhau, Mundra, and Kandla ports has continued through Q1, as we had guided earlier, and remains on track to be completed by end of September. The longer haul distance continued to affect fleet turnaround and fuel consumption, and is the single largest reason for our decline in salt in salt volumes and the profitability for the quarter.

We continue to expect this construction to be completed, as I said earlier, by end of September, after which we expect salt volumes to normalize and an improvement in our transportation costs as well. The cost of HSD continued to increase between April and June, though it has normalized in July.

Compared to last year, prices in April to June were nearly 60% higher. We have mitigated large part of this through route optimization, additional fleet contracting, commercial diligence, and revised dispatch scheduling, but we did see an impact through the quarter, which was quite significant.

Brine field expansions, which we spoke about last quarter, remain on schedule. We've completed most of phase one, and we are optimistic that we'll actually be able to prepone commissioning of phase one to post the monsoons.

The land lease extension discussions are ongoing, and we remain positive of closure of the same in the coming months. Let me now talk about the businesses in a little bit more detail.

The bromine segment delivered a revenue of ₹1,333 million, up by 58% year-on-year on volumes of 4,175 tonnes. Realizations are broadly were up, and we expect them to largely remain firm near the ₹300 per kg level.

On production levels, which we had recovered from have recovered from mid-February, and have fully sustained themselves through the quarter. As guided earlier, our throughput has been improving steadily, and we expect the quarterly run-rate to improve.

Production was up 7% year-on-year despite lower GPL, and we also had an impact of around three days of production due to grid power shortages and scheduled maintenance programs, which are designed to debottleneck our capacity through the rest of the year. Industrial salt generated revenue of ₹1,713 million on volumes of 982,000 tonnes, down 12% on a year-on-year basis.

Dispatches were impacted by vessel shortages, fuel supply shortages of diesel, and order deferments due to the ongoing West Asia conflict, resulting in higher finished goods inventory. Logistics and transportation costs, as mentioned earlier, are expected to normalize over the coming months as both diesel prices normalize and the highway infrastructure work is completed.

We expect good recovery from Q3 of this year. Bromine derivatives, it's a quarter, an important quarter for Acume Chemicals as it turned EBITDA positive.

Acume delivered EBITDA of ₹19 million this quarter against an EBITDA loss of ₹27 million in Q1 of last year. Revenue was up 28% year-on-year.

We continue to focus on a richer, higher-value basket, and the operating leverage is beginning to show up. Organic derivatives contributed meaningfully to the year with a large increase in our NPBR volumes.

Capacity utilization for the quarter was around 40%, and contribution margins will continue to improve as utilization builds and as a share of the organic derivatives share of the basket increases. The company has launched new products earlier this year with additional products under development on campaign basis, such as NPBR for pharma, additional spec variants of CABR, and so on.

Moving on to sulphate of potash, the reengineering of the manufacturing process which we described in the last call has largely been positive, and we continue to work on completing phase two trials by December of this year. SOP revenue for Q1 was ₹113 million against ₹35 million for the full of last year.

Right, with the technology successfully proven, focus is now on finishing phase two trials and then redoing our operational processes and then kind of scaling up volume. Higher sulphate prices do remain a near-term challenge from a feedstock sourcing perspective.

The oilfield chemicals business, or Idealis as we call it, revenue was remained muted and was around ₹3.5 million for the quarter as we continue to focus on plant readiness and trial customers' orders. This business is in early stage, and we're investing ahead of revenue, with an EBITDA loss of ₹13.4 million in the quarter.

Customer trials continue to progress as the three plants commissioned over the where we started the work over the last 12 months. Gujarat plant is production ready, and we have now and we continue to wait for necessary state approvals there.

At Nagari in Andhra Pradesh, we have completed the redeposition of our product roadmap for starch and PAC, and we are now working on developing those products, and some products are actually in the middle of customer trials. Semicon project in or SiChem in Odisha, following the fiscal support agreement signed with the Government of India, we are moving firmly into execution as per schedule.

As far as energy storage, the Offgrid Energy Labs business is concerned, our investee company has inaugurated 10 megawatt hour ZincGel battery pilot facility at Hook in the United Kingdom. We are in the process of they are in the process of stabilizing operations of the pilot, and over time, this will be a source of pull-through demand for our for zinc bromide in our larger derivatives portfolio.

Now talking about the financial numbers in more detail, let me begin with standalone performance. On a standalone basis, total income for Q1 FY27 was ₹3,321 million, a growth of 14% year-on-year and 9% sequentially.

The business mix in the standalone business for the quarter was industrial salt was 54%, bromine sales was 42%, and SOP was 4%. In terms of geographic mix, exports was around 70% of demand compared to 78% for the same quarter last year, and domestic business was around 30% of our volumes, up from 22% last year.

This largely reflects a shift in our product mix of due to higher sales of bromine and SOP in the quarter. EBITDA for the quarter was ₹839 million, with a margin of 25.3%.

On costs, employee cost is ₹162 million, and other expenses were ₹2,063 million against ₹1,664 million. This increase in other costs was largely driven by increase in two large elements.

We had a sharp increase in our freight costs due to higher logistics costs, which we have discussed in detail, and secondly, we had higher costs in stores and spares this quarter. If you recall early in my comments, I'd mentioned that we took planned outages in the quarter to support some of our debottlenecking programs for the rest of the year, and those resulted in higher stores and spares expenses during the quarter.

Overall, I think the large the large part, obviously a dominant part of it was logistics costs, which, as we mentioned earlier, we expect to start tailing down with lower fuel prices and obviously the the highway construction getting completed by end of Q2. Depreciation was ₹199 million for the quarter, and finance cost was ₹86.4 million against ₹44.6 million for the for the previous year.

Profit before tax was ₹553 million, and standalone profit after tax is ₹405 million. On a consol basis, total income for Q1 was ₹3,328 million, up 10.7% year-on-year and 8.6% sequentially.

EBITDA was ₹728.7 million. Profit after tax was ₹442.2 million, and PAT was ₹303.5 million against ₹132.3 million in the prior quarter.

Basic EPS was ₹2.48 for the quarter. Large part drivers in the consol performance were really the standalone performance.

The impact of the cost increase in our standalone performance largely drove the decline in the consol performance as well. From an entity perspective, Acume delivered revenues of around ₹300 million, up 28.1%, and a positive EBITDA of ₹19 million against a loss of ₹27 million a year ago.

Its loss before tax narrowed to ₹58.6 million, down from ₹103.3 million in the previous year, which is a 40% improvement. Idealis reported revenues of ₹3.5 million, with an EBITDA loss of an EBITDA loss of ₹13.4 million for the quarter.

Nuchem and SiChem collectively, on a consol basis, reported revenues of ₹0.4 million, with an EBITDA loss of ₹5.6 million, as both of them as that business largely remains in the investment phase. A detailed breakup of the sum of the parts and our constituent elements of our consolidated performance is provided in the earnings deck on our website.

Before I close, let me quickly summarize key priorities and outlook. To summarize the quarter, I think sequential improvement across all our line items.

Margins were up by around 340 basis points versus the prior quarter, and a continued shift towards higher value volume business mix, a broader customer base, and a stronger balance sheet. Our three priorities, which we I'd outlined to you in the last couple of calls calls, remain unchanged.

Continuing the core salt and bromine business remains the focus. Bromine is recovering and improving, and salt pricing has stabilized.

With the change in transportation infrastructure and softening of fuel prices, we expect that to be back move to a higher gears. Scaling up our derivatives business, which is oilfield chemicals and our mud chemicals business, is the second priority which we have detailed.

Our derivatives business is now EBITDA positive, and we are now in customer trials for several products in our mud chemicals business. We continue to invest in long-term opportunities in advanced materials.

SiChem is now in execution phase, right, Offgrid has started its pilot, pilot plant, and we continue to remain committed to these investments, which we think are going to be very accretive in a 24 to 48-month window for the company. We continue to remain focused on stronger cash flow and more disciplined capital allocation.

For the balance of FY27, we expect salt volumes to normalize from Q3 as the highway work completes. We are focused on holding our guidance, which we had given earlier, in terms of bromine volumes, and and obviously in trying to maintain our maintain most of the price increases which we have which we have implemented, derivatives to continue to build on break-even and continue to scale up volume, and completing our SOP scale-up by the end of this year.

Therefore, I think we feel positive about where we are in the early part of the second quarter of the year. With that, let me open up the floor for questions, and I'll come back towards the end for closing comments.

Operator

Thank you very much. We will now begin the question and answer session.

Anyone who wishes to ask a question may press star and one on their touchtone telephone. If you wish to remove yourself from the question queue, you may press star and two.

Participants are requested to use handsets while asking a question. Ladies and gentlemen, we will wait for a moment while the question queue assembles.

Participants, you may press star and one to ask a question. First question is from the line of Sanjesh from ICICI Securities.

Please go ahead.

Sanjesh Jain

Good morning, Ram.

Rampraveen Swaminathan

Good morning, Sanjesh.

Sanjesh Jain

Thank you, sir. I've got a couple of questions.

First on the bromine volume, we did 4,175 metric tonne in this quarter. We guided for around 20,000 metric tonne for FY27, and we said in the previous quarter that we have reached a production of 55 metric tonne per day, which should have actually translated to 4,500 metric tonne.

Where is the gap, and are we still confident of achieving a 20,000 metric tonne kind of a volume for FY27? That's number one.

Another question on bromine is a pricing. We generally do an annual contract for export.

Now that the realization have crossed ₹300, is it fair to assume that next three, four quarter the realization barring domestic volatility should be in the range of 300, which you did mention, but how strong is the outlook for the pricing? These are the questions on the bromine.

Rampraveen Swaminathan

Let me address the pricing issue first. Obviously very volatile pricing environment.

That goes without saying. As I said, there's always concerns when the price are going up sharply and their concerns when prices come down sharply as well.

I think from our perspective, 60% of our business to 70%, as I said earlier, is long-term contracts, and the 30, 35% has been short-term spot businesses. We are reasonably confident, obviously customers are raising concerns around pricing for sure, but we do believe strongly that we'll be able to hold and weighted average blend, which I mentioned earlier, on the external market.

Remain fairly confident about that. There is obviously work to be done there, but we believe strongly in the customer partnerships and a historical long-term approach we have used with them, that should hopefully reap us benefits.

Some impact will be there on spot segment of the business, but we are working closely to ensure the blend is in line with what I had said earlier, right? In terms of volume, firstly, I think I just want to restate what I had said earlier on was that we expect to exit the year at the 2025 20 to 25,000-tonne run-rate, and you are right that would basically translated to 4,500 tonnes for the quarter.

We had two challenges or two things which really impacted the volume. I think we are 325 tonnes short in the quarter.

A part of that was power shortages in the region. During the quarter, we had sudden power cuts, right, in the grid power supply, and that meant that we obviously have to shut down, restart plants, and work through it.

We probably lost three days of production, three three and a half days of production there, which was probably close to around 175 to 200 tonnes. We also took planned shutdowns.

As Q2 and Q3 is really the real test of our improvement. I don't really like to consider Q1 as a test of our improvement.

Last year, I think the Q2 was down to around 3,000 tonnes. Right?

We are continuing to working on debottlenecking the plant, and we did take around two to three days of additional shutdown on the feed stock plant in terms of upgrading some of the infrastructure on the feed stock plant to drive improved recovery. One of things which you'd be aware of, Sanjesh, is that there's been a very high inflation in cost of sulphur, right, through the quarter, through the last five months, which is largely the Middle East, a big source of sulphur manufacturing.

There's been a fairly large increase in coal costs, which have almost doubled. The improvement in recovery is part of how we have been able to offset those cost increases.

It's not just an improvement in throughput which has happened. We've also been able to chemically improve recovery, and that has actually helped offset the cost increases.

We have to continue to invest in the plant upgradations and debottlenecking to ensure that happens. It's obviously a multiple set of factors we are working with, but I think broadly at a headline level, I continue to believe that we remain on track to what I'd said earlier last quarter.

Confident about that. We are working on it.

As I said, Q2 and Q3 will be meaningful opportunities for us to demonstrate that improvement. In Q1, GPL did decline versus last year, but we still were able to show a 7% production improvement despite that lower GPL, which I think is a reflection of the work.

I think broadly, 100 and we lost probably 200 tonnes because of power, and we lost around 150 tonnes because of our plant shutdowns. Without that, we had been at the 4,500 level.

Sanjesh Jain

Very clear. Thanks, Ram.

That's super clear. Second, on the salt, we said there was some volume spillover from last quarter also if I read Q4 concall.

This quarter, it's more seasonality, demand, postponement of Middle East, or you see there is real challenge because caustic soda prices have been quite firm up. Demand could not have been a issue, right?

I think

Rampraveen Swaminathan

overall chlor-alkali has remained positive, though I would say that the conflict has impacted some amount of PVC demand, which obviously has some flow-through into our business. Overall at a headline level, demand has not moved backwards at all, Sanjesh, so that's remains positive.

I think our challenges is if you remember last quarter, I think we told you that we had around 120,000 tonnes of shipment 110,000 tonnes of shipment being impacted, one because of a order deferral from QVC as they continue to see the Middle East crisis, and one ship which got deferred because of logistics issues. This quarter, we've seen the same issue, right?

I think we've seen QVC actually remains on hold, right, because of the conflict situation is not really fully eased for them to start operations. We continue to have a lot of issues on logistics.

As I mentioned, while we talk a lot about road logistics, Sanjesh, the actual reality is that sea freight has also reflected a sharp increase in both of change in trade flows and the increase in fuel costs. That has meant that 70 60 to 70% of our volume is customer-nominated vessels.

Therefore, we have been obviously seeing deferrals, delays, bunkering issues, right, and those kind of challenges which are there, berthing issues, and so on and so forth, which has resulted in delays. It's affected our bromine and derivative business as well, by the way.

It's not just an issue of salt. It gets called out a lot for salt because bromine is performing positively, but in bromine as well, we've had issues, and derivatives as well.

Towards the end of the quarter, we had cutoff issues with vessels not getting loaded, the vessels from Hazira not being available, slots not being there. Those challenges remain.

What we have done, and actually I probably called this out earlier as well, what we have done in this quarter is we also started this quarter, which is we will start in Q2 in July-September quarter, is we'll also start shipments from Kandla. By increasing our throughput overall spread from two ports to three ports, we've just built our stockyard out in Kandla.

As you start building that, Sanjesh, what will happen is that our flexibility on shipments will improve, and freight liners who are running to Kandla but not Mundra will actually find it more easy to berth and will not do blank sailings on us. There is work happening to solve that problem, but that is the way the situation is right now.

I think we also tried to exercise commercial discipline on some contracts, right, which also has probably impacted us a little bit, though we've not seen any actual order loss because of that, where we are trying to pass through this cost increase to our customers. That's something which you are trying to push a lot on as well because of the large increase in costs.

That to some extent probably has affected our conversion rates as well, which I hope will pick up from Q3 onwards.

Sanjesh Jain

Just one last on the SOP. What was the volume this quarter, and 2,000

Rampraveen Swaminathan

2,200 tonnes.

Sanjesh Jain

Whether this run-rate will continue until we completely

Rampraveen Swaminathan

Sorry, I just stand corrected. I think actual volume of sale was 1,952.

I probably referred to a production number. Actual sales quantity was 1,952 at an average realization of you could do the math, but roughly around ₹58,000 ₹58,000 per tonne.

Sanjesh Jain

Got it. Whether this number at least is sustainable through the year or even this could be volatile?

Rampraveen Swaminathan

No, obviously feedstock affects it, Sanjesh. Our business pretty well.

As I said, as I've said towards as I said last quarter, for the full year, our target is to do around 9 to 10,000 tonnes, and we still remain very confident about ability to do that throughput. In terms of month-to-month variations, to some extent it depends upon actual feedstock quality, which comes from the crystallizers, and what kind of yield we can get.

The 10 to 11,000 tonnes which I've given as 9 to 10,000 tonnes I had given last quarter as an target for the quarter for the year, we still remain positive on that, and we've been trying to push production up, which is why this quarter, as you've seen, we've actually been able to do nearly 2,000 tonnes. We are we're on on it, though I won't say that that's going to happen month on month.

If you ask me that question, I can't say for sure that's going to happen month on month, but full-year number we still remain by stay by it. Very clear.

Sanjesh Jain

Very clear. On the bromine derivative, what really drove to the break-even, and this break-even will continue and volume ramp-up will continue from this level?

Rampraveen Swaminathan

I think it's it's three things. I think first of all, it's it's increasing volumes from improving mix.

If you look at it historically, till last year, our focus really was our volumes largely were CBF, clear brine fluids, products like CABR and sodium bromide. We actually have stopped making sodium bromide because the yields were very low on it, and we repurposed that demand back to to calcium bromide.

We've also had a increase in NPBR volumes, which last year, for example, were same quarter last year were around 25, 30 tonnes. This quarter has been on 300 350 tonnes for the quarter.

Right? Organics organic derivatives actually give us much better are at a higher end of the pricing basket.

One big lever is is the is the product mix itself. More products are under release right now, right.

We are working on several alkyl bromides and also derivatives of our existing products. I mentioned in my earlier comments, this quarter, for example, we released a pharma-grade NPBR, which will allow us to basically, get more penetration on the pharma demand.

One part was was that. The second part obviously was cost management at the Jhagadia plant.

With higher volume, we're also able to optimize our BCT, our batch compression times, our consumption of n-propanols and several other elements which are there in our in our consumption basket. The third one obviously was commercial discipline.

As we did just as we did price increase in bromine, our focus was higher commercial discipline in derivatives as well.

Operator

Thank you very much. Sanjesh, sorry to interrupt.

I'll request you to come back, please.

Sanjesh Jain

Yes, thank you.

Operator

Thank you so much. I request all the participants, kindly limit yourself to two questions per participant, and rejoin for a follow-up question.

Next question is from the line of Aditya Khetan from SMIFS Institutional Equities. Please go ahead.

Aditya Khetan

Thank you, sir, for the opportunity. Sir, just a couple of questions.

Sir, first, my question is on to the cost side. As you mentioned in your presentation that there were some route changes like from A to D, now we have changed it to A, B, C, D.

Diesel prices also you mentioned are up by some 50%. Sir, what if tomorrow all the cost come down so the diesel prices and the freight route also becomes our earlier route, how much savings in cost per quarter and also on an annual basis we can see?

Rampraveen Swaminathan

I think at a simplistic, let me just look at the past, because that's probably a good indication of the future rather than giving you an guidance on this. I think what you've seen that our other costs have increased, if you look at our results on the website, our other costs have increased by approximately ₹40 crores year-on-year.

Around 60% of that was really driven due to the increase in logistics costs. Right?

That logistics cost is divided roughly 60-40. 60% is the increase in distance.

For example, Jakhau, Mundra, which used to be from the plant to Jakhau and Mundra, which used to be I'd say 270 to 350 km, Jakhau has doubled to 500-plus km, and Mundra went up by 40 to 50% because the road change. That's roughly 60% of the number, and 40% of it has been the diesel price increase, right, which has been a factor which, as I said earlier, has gone up by around 40 to 50% year-on-year.

Both of these as they get normalized will basically reflect back in our earnings. Right?

We have obviously mitigated that some amount of the diesel price increases, all of that has not gone through. We have reduced vehicle downtime.

We've improved the rerouting. We've done our best to kind of reroute and improve roads, schedule vehicles differently, source from multiple new locations.

Doing those things have actually helped us mitigate some of it, but at a headline level, I think a large part of this cost increase will get mitigated as the resets happen. As fuel prices come down and as the roads get reset, this is not a structural cost increase, these are short-term issues which we have to just work through.

As I said, fundamental dynamics of business in salt remain positive, our customer relationships remain intact. We've gone from two ports to three ports.

We've created stockyards in all three ports now. We expanded our own fleet to reduce dependence on old, inefficient market fleet to become more efficient in terms of fuel efficiency and improve the TAT times of vehicles.

All of these should start, I wouldn't say bleeding in, but they should start reflecting our numbers in Q3, and should help us first improve profitability and then secure more demand as well.

Aditya Khetan

Got it, sir. Sir, my second question is on to the pricing of the bromine derivatives.

We look at this quarter, bromine prices are up by 25%, but the bromine derivatives are up by only 10%. Should we assume in the subsequent quarters that 15% gap of higher realizations would be recouped by the bromine derivatives with a lag effect, first, sir?

Second, sir, adding on to this, any updates sir on to the lease side like we have also mentioned in our results that we are quite confident on to it. Sir, when I look at so two to three years back, government was more keen for the bidding process.

Has that changed and government is now awarding to the players who have existing brine? Has that policy been changed by the government and what gives you the confidence, yeah.

Rampraveen Swaminathan

Let me respond to two things. I think I'm not sure about the numbers you quoted on bromine derivatives specifically, and I think if you reach out to our team, we will give you specific numbers on this, more specific numbers.

Broadly, one thing which I would just say is that bromine, depending upon the derivative we use, bromine is a percentage of the cost. It could be 40%, could be 50%.

For example, in calcium bromide, bromine is around 50% of the cost. If bromine goes up by x, you must just recognize that bromine derivatives will go up by that fraction of x in a perfect world.

In a perfect world, they'll go up by that fraction of x. Therefore to assume that bromine is up 25% or 50% and therefore derivatives price will increase by the same percentage is not actually a consistently defensible pricing action in the market.

If you reach out to our team, our investor relations team or our finance team, they'll give you more specific numbers about how those movements have happened. I would probably just say that your numbers don't seem very accurate at this stage, but directionally, it is right that we can never get the same price increase on derivatives as we get in bromine, all other things being equal, it's a fractionally cost increase.

Right? That's one.

As far the lease is concerned, I think I covered in my opening comments, we remain confident about closing this in the coming months and completing the agreement signing process with the government of Gujarat. To the best of my knowledge, and I will go back and check this back with our team, but I don't think there's been a bidding process on existing leaseholder in the state of Gujarat unless a leaseholder has not been paying money or there's been some performance issue or a lack of interest from the leaseholder.

I think to the extent we have known, that scenario has not happened. As I said, we are working very closely with the government.

We're very confident based on where we are in the discussions with them and the feedback from them that we expect to close this in the coming months. Operationally, as I've mentioned earlier, we continue to file our tack rents.

They continue to raise invoices for rents and accept those rents. We have been increasing rents as per the GO in terms of annual increases, which should be done once pricing should be done once in three years, and they have been accepting those price increases and raising demand notices on us in line with that.

We don't see any particular reason, and given the state of our negotiations right now, we remain pretty optimistic that this will get done in the coming months.

Aditya Khetan

Got it, sir. Thank you.

Operator

Thank you very much. I request all the participants, kindly limit yourself to two questions per participant.

Next question is from the line of Rohit Nagraj from 360 ONE Capital. Please go ahead.

Rohit Nagraj

Thanks for the opportunity, and congrats on the zinc bromide pilot plant commercialization. Sir, what are the timelines that we are looking at, given that this 10 megawatt pilot is now come up from this to 1 gigawatt scale capacity in India, how the process will be in terms of validations, qualifications, and in terms of the projects startup and then commissioning?

Broader timeline should also do. Thank you.

Rampraveen Swaminathan

Rohit, let me just frame this first by probably talking a little bit about how we see Offgrid, okay, because I think that has relevance to your question. I think we are investee in Offgrid.

We are a strategic investor in Offgrid. Offgrid has a management team which is working on the execution of the pilot.

Our interest on it has been threefold. One is I think as we see this Offgrid energy solutions first as a standalone business to be an interesting business opportunity for us.

Secondly, there is flow-through demand of chemicals, especially zinc bromide, for us. We are the primary supplier of zinc bromide for the Offgrid business.

Third one obviously is a chance for us to build up and scale up megawatt-plus kind of projects in India, right? Now, these three have to be seen with very different timelines because they all are not compressible into one natural flow, right?

Firstly, I think they have right now launched the 10 megawatt pilot. Obviously, a plant of this scale cannot be determined to be successful immediately, right?

The management team of Offgrid, which is responsible for success of this pilot operationally, is working on the execution of the pilot, and I would say it's probably going to be several months before we can actually say that it is completely done and gung-ho and is fully scalable. One has to go by their guidance and decisions on that.

Two, the second one is as our zinc bromide demand is concerned, we continue to supply them zinc bromide. As they need zinc bromide, we'll continue to supply them.

We are just finishing our REACH certification for zinc bromide of the Jhagadia plant, and once that happens, the volume will scale up further. I think it's after the pilot plant is fully demonstrated at scale and they look at scale-up of the business overall that we will actually look at megawatt-plus kind of plants in India, right?

That's phase three. That's horizon three.

I won't time it. I think it's difficult to put a specific time on it right now.

These are the three horizons. Horizon one is Offgrid's internal operations, which I think continue to focus on scaling up.

Horizon two is scaling up our zinc bromide delivery, which will happen along with their scale-up. Horizon three is working together with them on launching megawatt 10 megawatt-plus kind of power plants in India on a commercial power supply basis, which I think is a third horizon, which right now we've not specifically fixed a specific time around that.

Rohit Nagraj

Sure, sir. This is helpful.

Yeah. Sir, second question on the semicon project, where are we currently, and again here if we can give us a broader timelines as to how we are looking at the progress of the project?

Thank you.

Rampraveen Swaminathan

Let me give you an opening comment. I'll see if Rajeev wants to add a little bit more if he is closer to the actual scheduling of the project.

Broadly, I think we have said earlier 24 to 27 months, right, from, which is what we said last quarter, that once we finish the FSA, our target is to kind of get this done in 24 to 27 months. We are executing to that schedule, right?

That's broadly the number. Bear in mind that 24 to 27 months is commercial SOP, start of production, then of course scale-up takes time after that.

It's not a binary equation that the day we launch the plant, it immediately goes to 100% capacity. There's always a capacity ramp-up in these grand projects.

That's the high-level status. Let me see if Rajeev

Rajeev Kumar

Just to add to what Ram sir said, see, we signed our FSA with Government of India on 11th May. Post that, we have completed the other operational requirements like signing of TRA agreement and some other documents.

We are currently in the process of obtaining the environmental clearance and consent to establish, post which the construction work will start. Sometime late August, early September is when the construction work will start.

We have already onboarded the general contractor. The design readiness, in fact the overall basic and detailed engineering design Sir,

Operator

sorry to interrupt, you are sounding distant.

Rajeev Kumar

Is it better now?

Operator

Yes, sir.

Rajeev Kumar

Yeah. On the design front, we are progressing as per the schedule.

When we plan to start late August or early September, our design readiness will be very much there, and we so far are on the schedule.

Rohit Nagraj

Perfect. That is helpful.

Just one last clarification on the production volumes of salt. We have generally been about 1.1 million tonnes a quarter.

Given that last quarter we had logistical challenges, we still have some inventories and which can be liquidated throughout the rest of three quarters?

Rampraveen Swaminathan

Yeah. I think we have some this quarter I think inventory increased.

I think generally in Q1, we tend to add inventory, and Q2 as the monsoons come in, we tend to optimize a little bit of harvesting and washery manufacturing operations, we can ship more from inventory. This quarter actually we kind of cut down a little bit of manufacturing as well because of the high fuel costs, right, to optimize the fuel costs.

We actually downsized a little bit of our washery and harvesting operations as well, but we do have inventory for us. It's a small amount, which will get liquidated as a normal course through the rest of the year.

I do expect that we'll have double-digit growth from Q3 onwards of salt, right, as we can't wait to ramp up and things get a bit more smoother with the overall environment and the logistics situation.

Rohit Nagraj

Sure. Thanks a lot, and all the best.

Operator

Thank you very much. Next question is from the line of Archit Joshi from Nuvama.

Please go ahead.

Archit Joshi

Hi, very good morning, sir. Thanks a lot for the opportunity.

Sir, my question is regarding the bromine industry particularly. If I just look at the historical volumes that we have done, taking into consideration that FY22 was the best possible year that anybody could have had in the chemical industry, we still had done about 20,000 tonnes in terms of volumes in FY22, and we're talking about the same number in FY27, roughly 20-odd thousand tonnes, hopefully recovering from the second quarter to the extent of 5, 5.5 thousand tonnes of quarterly volumes.

Sir, it's basically been a span of five years, and our volumes have sort of flattened out. Has this been a bromine industry-specific issue because we have almost 43,000 tonnes of capacity, had the potential of doing about 28,000 tonnes of merchant sales?

Where has the math gone wrong, sir, if you could explain your thoughts on the bromine industry?

Rampraveen Swaminathan

Yeah. I think it's hard to say the math has gone wrong, but I think for all the data points which you have shared are all very accurate.

As you look back into our past, I think they're all fairly accurate. I think overall, firstly, I would say from the industry structure perspective, the attractiveness of our industry segment still remains very positive.

Overall demand for bromine both through flame retardants, oil and gas, and agriculture are all positive headlines for the sector overall. There will be shifts which happen within those segments.

For example, in flame retardants, one brominated retardant, FR, might be replaced by another one, which is a monomer might be replaced by a polymer, and so on and so forth. Bromine's inherent characteristics lead themselves very strongly for the applications they're being used in, and I don't see any headwind from an industry structure perspective, at least for the next three to five-year window.

If anything, as electronics consumption increases, as India does more of Make in India, some of these things will actually be positive for us. I think the challenges of the last three, four years have been two, three two things broadly.

I think the first one has been that as the feedstock, our bromine depends upon brine which comes in from the sea. As the feedstock has changed and the brine characteristics have changed, obviously chemical system in terms of recovering bromine has to be modified for that.

We have seen that changing, which has been a structural change, I think, over the last four, five years, and probably one of the things which we could have done faster and better is basically making those changes in our design system to basically enhance our recovery performance. Improve our recovery performance, which is what we're working on right now.

The second thing, of course, has been, I would say, one-off events, right, sudden high amount of floods or rains, sudden amount of cyclonic behavior, etc. Average rainfall in Kutch region has gone up from around 50, 60 20 years ago to 900 today.

Obviously, we have seen more cyclonic kind of activity, and those results have at times resulted in sudden dilution of our brine and created operational issues which have been difficult to respond to in the short term. A good example of that is what happened last year in Q2, end of Q2, early Q3.

It's a combination of structural shift, which we are resolving, and some one-off events, which none of us is able to perfectly forecast. The structural ones are the things which we are taking actions on to kind of enhance and debottleneck our capacity.

Our goal is that we will be at a run-rate which is between 20 and 25,000 by the end of this year and the early next financial year. Annual run-rate.

Annual run-rate, yes, fully understood.

Archit Joshi

Understood. Sir, just two small follow-ups, and then I'll come back in the queue.

The 28.5-odd thousand tonnes of directional volumes that we plan to sell in the merchant market, when do you think that could be achievable? Has the industry also over the last five years been at the same level?

The data points that we have are roughly the bromine industry is to the extent of about 1-odd million tonnes. Has that numbers grown, and how do you see that growing?

Rampraveen Swaminathan

It's growing. I think it's growing.

I think in India, the challenge from domestic demand perspective obviously, FR, there's not any FR capacity in India, and therefore FR is the largest demand for bromine, and domestic demand kind of basically has a vacuum there, with most of it being imported directly and indirectly. Fundamentally, I think it's a low single digit to medium single-digit kind of growth sector, right?

I think from the numbers you said, I think broadly the way you have structured the numbers is our earlier comments that if we have 40,000 tonnes, then around 30 product mix of 30% to go to internal consumption and 70% to go to merchant. I'm assuming that's the way you've structured it, because that's probably what I and Natarajan and Rajeev have mentioned in calls or in analyst meetings.

I think that's probably 27-28 late, I would say 28-29 is, I think, financial year '28-'29 actually when we will be able to be in the range of that run-rate. As I have said earlier, we think that the 25,000 tonnage run-rate is something which will be able to accomplish through debottlenecking.

The 40,000 will require some more investment, which we will have to do, and we will time that investment along with our flame retardant project and the expansion in derivatives. Those will go hand in hand because adding that capacity without a clear demand pattern should not result in pricing pressure on our flow-through and volumes.

That investment is designed to be aligned together. That's why I think probably be 28-29.

We'll take that call exactly in the second half of next year, and then it's probably a three-quarter expansion, three-quarter amount of.

Operator

Thank you very much. Archit, I'll request to come back for a follow-up question.

I request all the participants, kindly limit yourself to two questions per participant and rejoin for a follow-up. Next question is from the line of Karan from Keynote Capitals.

Please go ahead.

Karan Galaiya

Yes, thank you for the opportunity. My first question is related to the brine quality at Archean.

Were there any issues due to the rainfall this time?

Rampraveen Swaminathan

No, not really. I think, as I said, as I mentioned earlier, brine GPL was lower than last year, but it's what we expected it.

It's in line with what we're designing our operations for.

Karan Galaiya

Got it. Sir, second thing I wanted to understand is related to the Idealis market and the drilling chemicals that you are working on.

As oil prices have surged, and government is also focusing a lot on increasing the seismic activity by funding them, just wanted to check how has been the demand for these products right now? How are you expecting it to scale down the line?

Rampraveen Swaminathan

I think our oilfield chemicals business is largely driven by exploration and not so much by production. Production to some extent, but exploration is a larger driver.

If you look at the global market, I think the large part of that market is still overseas and outside India. While the government is increasing capacity investments, there aren't too many huge investment expansions happening in terms of offshore drilling in India.

There's a lot of wells which are basically being drilled, but they are not yet close to a production phase, right, in terms of the actual activity. Therefore, the size of the market is actually quite small.

Demand is still largely driven by overseas markets, both in Middle East, Africa, and of course with the increasing amount of shale production in the US, which requires slightly different products in terms of well management for shale. Slightly different elements, but fundamentally that demand pattern still remains stable.

I think we make starch, PAC, and we make some thickeners like barite and viscosity products like barite and bentonite, and fundamentally demand for them at a category level is still pretty robust. Our challenges remain what we articulated before: getting the plants cleared from a technical perspective for production, then getting the licenses and agreements sorted out, and then getting the new products developed.

In the last three, four years, obviously markets have shifted, right, and therefore the product plan is something we've had to revisit and lay out a new product plan, which we are in the process of completing that. For PAC and starch, we have laid out a future product plan.

We're developing new products, and some of them are in customer trials. It is a cycle which has to go through.

The oil industry, though for good reasons, is an industry which is a long-cycle adoption industry, and therefore it takes us time for us to go through customer trials and drive volume growth in the sector.

Karan Galaiya

Got it. When we are expecting these volumes to run?

I think, yeah,

Rampraveen Swaminathan

I think we are hoping to have meaningful volumes in the second half of this year for PAC and starch, and then probably by the end of the year for bentonite, and barite will follow. Just a reference for you, PAC and starch is Nagari plant in Andhra, and bentonite is the Mandvi plant in Gujarat.

Operator

Thank you very much. The next question is from the line of Darshita Shah from DSP Mutual Fund.

Please go ahead.

Darshita Shah

Hi. Thank you for the opportunity.

Just one clarification. This year, we will end the quarter quarterly run-rate should be for bromine should be roughly about 20, 25,000 tonnes.

FY28, we should be able to do about 25,000 tonnes for full year?

Rampraveen Swaminathan

That's what we are committing towards, Darshita.

Darshita Shah

Got it.

Rampraveen Swaminathan

Same thing I said last quarter.

Darshita Shah

Great. Just one more question for Rajeev.

For semicon, once we start the construction, how should we think about the capex for the full year and then for FY28?

Rajeev Kumar

See, Darshita, the capex for semicon, which was $249 million, 15 to 20% of that has already been incurred, which ACIL, you would have seen, has already intimated the stock exchanges. The balance capex, around 60 to 65% of that will happen in this financial year, which will be mostly towards advances for plant and machinery and other equipments.

The balance 40, 45% will happen in the next financial year. That's how we should think about the overall capex for SiChem.

Darshita Shah

Got it. Great.

That's all from my side. Thank you.

Operator

Thank you very much. Ladies and gentlemen, that was the last question for today.

Rampraveen Swaminathan

I

Operator

now hand the conference over to Mr. Rampraveen Swaminathan, Managing Director, for closing comments.

Rampraveen Swaminathan

Thank you, everyone, for joining us today. We appreciate your time and your continued interest in the company.

I think at an overall level, I believe Q1 has given us a good start for FY27, and we are confident about the path ahead. In case of any queries, please do get in touch with us or with the SGA, investor relations teams.

We look forward to meeting all of you at the next call. Thank you for your continued interest, and stay safe.

Thank you very much.

Operator

Thank you very much. On behalf of Archean Chemical Industries Limited, that concludes this conference.

Thank you for joining us, and you may now disconnect your lines. Thank you.